Despite a clear description of clinical features, the condition is often misdiagnosed or underdiagnosed. Currently, there is no single diagnostic test for RLS. The disorder is diagnosed clinically by evaluating the patient's history and symptoms.
In 1995, the International Restless Legs Syndrome Study Group identified four basic criteria for diagnosing RLS:
(1) a desire to move the limbs, often associated with paresthesias or dysesthesias,
(2) symptoms that are worse or present only during rest and are partially or temporarily relieved by activity,
(3) motor restlessness, and
(4) nocturnal worsening of symptoms.
Although about 80 percent of those with RLS also experience PLMD, it is not necessary for a diagnosis of RLS. In more severe cases, patients may experience dyskinesia (uncontrolled, often continuous movements) while awake, and some experience symptoms in one or both of their arms as well as their legs. Most people with RLS have sleep disturbances, largely because of the limb discomfort and jerking. The result is excessive daytime sleepiness and fatigue.
Despite these efforts to establish standard criteria, the clinical diagnosis of RLS is difficult to make. Physicians must rely largely on patients' descriptions of symptoms and information from their medical history, including past medical problems, family history, and current medications. Patients may be asked about frequency, duration, and intensity of symptoms as well as their tendency toward daytime sleep patterns and sleepiness, disturbance of sleep, or daytime function. If a patient's history is suggestive of RLS, laboratory tests may be performed to rule out other conditions and support the diagnosis of RLS. Blood tests to exclude anemia, decreased iron stores, diabetes, and renal dysfunction should be performed. Electromyography and nerve conduction studies may also be recommended to measure electrical activity in muscles and nerves, and Doppler sonography may be used to evaluate muscle activity in the legs. Such tests can document any accompanying damage or disease in nerves and nerve roots (such as peripheral neuropathy and radiculopathy) or other leg-related movement disorders. Negative results from tests may indicate that the diagnosis is RLS. In some cases, sleep studies such as polysomnography (a test that records the patient's brain waves, heartbeat, and breathing during an entire night) are undertaken to identify the presence of PLMD.
The diagnosis is especially difficult with children because the physician relies heavily on the patient's explanations of symptoms, which, given the nature of the symptoms of RLS, can be difficult for a child to describe. The syndrome can sometimes be misdiagnosed as "growing pains" or attention deficit disorder.
DO NOT disregard medical advice or delay in seeking it because of something you have read on the Internet.
Topics
-
►
2009
(4)
- ► 04/05 - 04/12 (3)
- ► 03/01 - 03/08 (1)
-
►
2008
(10)
- ► 12/21 - 12/28 (8)
- ► 10/26 - 11/02 (2)
Friday, December 26, 2008
What is the prognosis?
RLS is generally a lifelong condition for which there is no cure.
Symptoms may gradually worsen with age, though more slowly for those with the idiopathic form of RLS than for patients who also suffer from an associated medical condition.
Nevertheless, current therapies can control the disorder, minimizing symptoms and increasing periods of restful sleep.
In addition, some patients have remissions, periods in which symptoms decrease or disappear for days, weeks, or months, although symptoms usually eventually reappear.
A diagnosis of RLS does not indicate the onset of another neurological disease.
Symptoms may gradually worsen with age, though more slowly for those with the idiopathic form of RLS than for patients who also suffer from an associated medical condition.
Nevertheless, current therapies can control the disorder, minimizing symptoms and increasing periods of restful sleep.
In addition, some patients have remissions, periods in which symptoms decrease or disappear for days, weeks, or months, although symptoms usually eventually reappear.
A diagnosis of RLS does not indicate the onset of another neurological disease.
How is restless legs syndrome treated?
Although movement brings relief to those with RLS, it is generally only temporary. However, RLS can be controlled by finding any possible underlying disorder. Often, treating the associated medical condition, such as peripheral neuropathy or diabetes, will alleviate many symptoms. For patients with idiopathic RLS, treatment is directed toward relieving symptoms.
For those with mild to moderate symptoms, prevention is key, and many physicians suggest certain lifestyle changes and activities to reduce or eliminate symptoms.
Decreased use of caffeine, alcohol, and tobacco may provide some relief.
Physicians may suggest that certain individuals take supplements to correct deficiencies in iron, folate, and magnesium.
Studies also have shown that maintaining a regular sleep pattern can reduce symptoms. Some individuals, finding that RLS symptoms are minimized in the early morning, change their sleep patterns.
Others have found that a program of regular moderate exercise helps them sleep better; on the other hand, excessive exercise has been reported by some patients to aggravate RLS symptoms.
Taking a hot bath, massaging the legs, or using a heating pad or ice pack can help relieve symptoms in some patients.
Although many patients find some relief with such measures, rarely do these efforts completely eliminate symptoms
Physicians also may suggest a variety of medications to treat RLS. Generally, physicians choose from dopaminergics, benzodiazepines (central nervous system depressants), opioids, and anticonvulsants. Dopaminergic agents, largely used to treat Parkinson's disease, have been shown to reduce RLS symptoms and PLMD and are considered the initial treatment of choice. Good short-term results of treatment with levodopa plus carbidopa have been reported, although most patients eventually will develop augmentation, meaning that symptoms are reduced at night but begin to develop earlier in the day than usual. Dopamine agonists such as pergolide mesylate, pramipexole, and ropinirole hydrochloride may be effective in some patients and are less likely to cause augmentation.
In 2005, ropinirole became the only drug approved by the U.S. Food and Drug Administration specifically for the treatment of moderate to severe RLS. The drug was first approved in 1997 for patients with Parkinson’s disease.
Benzodiazepines (such as clonazepam and diazepam) may be prescribed for patients who have mild or intermittent symptoms. These drugs help patients obtain a more restful sleep but they do not fully alleviate RLS symptoms and can cause daytime sleepiness. Because these depressants also may induce or aggravate sleep apnea in some cases, they should not be used in people with this condition.
For more severe symptoms, opioids such as codeine, propoxyphene, or oxycodone may be prescribed for their ability to induce relaxation and diminish pain. Side effects include dizziness, nausea, vomiting, and the risk of addiction.
Anticonvulsants such as carbamazepine and gabapentin are also useful for some patients, as they decrease the sensory disturbances (creeping and crawling sensations). Dizziness, fatigue, and sleepiness are among the possible side effects.
Unfortunately, no one drug is effective for everyone with RLS. What may be helpful to one individual may actually worsen symptoms for another. In addition, medications taken regularly may lose their effect, making it necessary to change medications periodically.
For those with mild to moderate symptoms, prevention is key, and many physicians suggest certain lifestyle changes and activities to reduce or eliminate symptoms.
Decreased use of caffeine, alcohol, and tobacco may provide some relief.
Physicians may suggest that certain individuals take supplements to correct deficiencies in iron, folate, and magnesium.
Studies also have shown that maintaining a regular sleep pattern can reduce symptoms. Some individuals, finding that RLS symptoms are minimized in the early morning, change their sleep patterns.
Others have found that a program of regular moderate exercise helps them sleep better; on the other hand, excessive exercise has been reported by some patients to aggravate RLS symptoms.
Taking a hot bath, massaging the legs, or using a heating pad or ice pack can help relieve symptoms in some patients.
Although many patients find some relief with such measures, rarely do these efforts completely eliminate symptoms
Physicians also may suggest a variety of medications to treat RLS. Generally, physicians choose from dopaminergics, benzodiazepines (central nervous system depressants), opioids, and anticonvulsants. Dopaminergic agents, largely used to treat Parkinson's disease, have been shown to reduce RLS symptoms and PLMD and are considered the initial treatment of choice. Good short-term results of treatment with levodopa plus carbidopa have been reported, although most patients eventually will develop augmentation, meaning that symptoms are reduced at night but begin to develop earlier in the day than usual. Dopamine agonists such as pergolide mesylate, pramipexole, and ropinirole hydrochloride may be effective in some patients and are less likely to cause augmentation.
In 2005, ropinirole became the only drug approved by the U.S. Food and Drug Administration specifically for the treatment of moderate to severe RLS. The drug was first approved in 1997 for patients with Parkinson’s disease.
Benzodiazepines (such as clonazepam and diazepam) may be prescribed for patients who have mild or intermittent symptoms. These drugs help patients obtain a more restful sleep but they do not fully alleviate RLS symptoms and can cause daytime sleepiness. Because these depressants also may induce or aggravate sleep apnea in some cases, they should not be used in people with this condition.
For more severe symptoms, opioids such as codeine, propoxyphene, or oxycodone may be prescribed for their ability to induce relaxation and diminish pain. Side effects include dizziness, nausea, vomiting, and the risk of addiction.
Anticonvulsants such as carbamazepine and gabapentin are also useful for some patients, as they decrease the sensory disturbances (creeping and crawling sensations). Dizziness, fatigue, and sleepiness are among the possible side effects.
Unfortunately, no one drug is effective for everyone with RLS. What may be helpful to one individual may actually worsen symptoms for another. In addition, medications taken regularly may lose their effect, making it necessary to change medications periodically.
RLS and MS
High prevalence of restless legs syndrome in multiple sclerosis. Manconi M; Fabbrini M; Bonanni E, Filippi M, Rocca M, Murri L, Ferini-Strambi L. European Journal of Neurology. 2007;14:534-9.
Background:
Multiple sclerosis (MS) is a chronic disease that affects the central nervous system. It can cause a variety of symptoms involving sensation, vision, speech, strength, mobility, and pain. “Secondary RLS” is a term used to describe RLS that has either a known cause or a known association. Some of the neurological diseases associated with RLS are peripheral neuropathy, spino-cerebellar ataxia, and Parkinson’s disease. Patients with MS often complain of RLS symptoms. This has always been viewed more as coincidence than as a real association between these two conditions.
Research:
The researchers wanted to see how common RLS was in patients with MS. Over the course of one year, every patient with MS that came to one of the two neurology clinic research sites was evaluated for this study. Patients were not allowed to be in the study if they had any other neurological condition or other medical condition that could cause secondary RLS. They were also excluded if they were on dopaminergic or neuroleptic drugs or clonazepam, and if they: (1) were diagnosed with MS within 6 months; (2) their MS had relapsed within the last 6 months; (3) had any drug or alcohol abuse; (4) had any dementia; (5) or if they were younger than 18 or older than 65 years old. In total, 156 patients (100 females and 56 males) were enrolled in this study. Each patient was examined by two physicians and evaluated for MS and RLS. They each had an MRI as well.
The results of this study showed:• 91 (58.3%) patients never had RLS symptoms.• 51 (32.7%) patients had RLS symptoms more than once a week in the last 6 months.• 12 (7.7%) patients had RLS symptoms less than once a week in the last 6 months.• 2 (1.3%) patients had prior history of RLS but no active symptoms.
The Bottom Line: In patients with MS, the rate of RLS is three times higher than the average population. The researchers in this study suggest that MS be considered a cause of secondary RLS.
New Questions: The brain lesions of MS can be found in many places, but there was no association between the locations of the brain lesions and whether the patient also had RLS or not—why is this? What is it about MS that makes a person at higher risk for RLS?
Background:
Multiple sclerosis (MS) is a chronic disease that affects the central nervous system. It can cause a variety of symptoms involving sensation, vision, speech, strength, mobility, and pain. “Secondary RLS” is a term used to describe RLS that has either a known cause or a known association. Some of the neurological diseases associated with RLS are peripheral neuropathy, spino-cerebellar ataxia, and Parkinson’s disease. Patients with MS often complain of RLS symptoms. This has always been viewed more as coincidence than as a real association between these two conditions.
Research:
The researchers wanted to see how common RLS was in patients with MS. Over the course of one year, every patient with MS that came to one of the two neurology clinic research sites was evaluated for this study. Patients were not allowed to be in the study if they had any other neurological condition or other medical condition that could cause secondary RLS. They were also excluded if they were on dopaminergic or neuroleptic drugs or clonazepam, and if they: (1) were diagnosed with MS within 6 months; (2) their MS had relapsed within the last 6 months; (3) had any drug or alcohol abuse; (4) had any dementia; (5) or if they were younger than 18 or older than 65 years old. In total, 156 patients (100 females and 56 males) were enrolled in this study. Each patient was examined by two physicians and evaluated for MS and RLS. They each had an MRI as well.
The results of this study showed:• 91 (58.3%) patients never had RLS symptoms.• 51 (32.7%) patients had RLS symptoms more than once a week in the last 6 months.• 12 (7.7%) patients had RLS symptoms less than once a week in the last 6 months.• 2 (1.3%) patients had prior history of RLS but no active symptoms.
The Bottom Line: In patients with MS, the rate of RLS is three times higher than the average population. The researchers in this study suggest that MS be considered a cause of secondary RLS.
New Questions: The brain lesions of MS can be found in many places, but there was no association between the locations of the brain lesions and whether the patient also had RLS or not—why is this? What is it about MS that makes a person at higher risk for RLS?
Local RLS Physicians and Specilists
Click here for a list of specialistss in the local area
Our Medical Advisor ~
Dr. Scott Fromherz
Westside Sleep Center
7450 SW Beveland Street, Suite 120
Tigard, OR 97223
Phone: (503) 639-7000
If you have other physicians or specialists who you would like to recommend, please contact Delores at surplad@yahoo.com and/or 360-892-5907.
Our Medical Advisor ~
Dr. Scott Fromherz
Westside Sleep Center
7450 SW Beveland Street, Suite 120
Tigard, OR 97223
Phone: (503) 639-7000
If you have other physicians or specialists who you would like to recommend, please contact Delores at surplad@yahoo.com and/or 360-892-5907.
Click through the calendar and find out what's going on...
If you would like to post something on the calendar (IE - walk, coffee, etc), contact Delores at 360-892-5907 or surplad@yahoo.com.
Sunday, October 26, 2008
RLS (Restless Leg Syndrome)
What is restless legs?
What are common signs and symptoms of restless legs?
What causes restless legs syndrome?
How is restless legs syndrome diagnosed?
How is restless legs syndrome treated?
What is the prognosis of people with restless legs?
What research is being done?
Where can I get more information?
Information provided by NINDS which is part of the National Institutes ofHealth
What are common signs and symptoms of restless legs?
What causes restless legs syndrome?
How is restless legs syndrome diagnosed?
How is restless legs syndrome treated?
What is the prognosis of people with restless legs?
What research is being done?
Where can I get more information?
Information provided by NINDS which is part of the National Institutes ofHealth
Subscribe to:
Posts (Atom)
Medical & Scientific Information
RLS and MS
High prevalence of restless legs syndrome in multiple sclerosis. Manconi M; Fabbrini M; Bonanni E, Filippi M, Rocca M, Murri L, Ferini-Strambi L. European Journal of Neurology. 2007;14:534-9.
Background: Multiple sclerosis (MS) is a chronic disease that affects the central nervous system. It can cause a variety of symptoms involving sensation, vision, speech, strength, mobility, and pain. “Secondary RLS” is a term used to describe RLS that has either a known cause or a known association. Some of the neurological diseases associated with RLS are peripheral neuropathy, spino-cerebellar ataxia, and Parkinson’s disease. Patients with MS often complain of RLS symptoms. This has always been viewed more as coincidence than as a real association between these two conditions.
Research: The researchers wanted to see how common RLS was in patients with MS. Over the course of one year, every patient with MS that came to one of the two neurology clinic research sites was evaluated for this study. Patients were not allowed to be in the study if they had any other neurological condition or other medical condition that could cause secondary RLS. They were also excluded if they were on dopaminergic or neuroleptic drugs or clonazepam, and if they: (1) were diagnosed with MS within 6 months; (2) their MS had relapsed within the last 6 months; (3) had any drug or alcohol abuse; (4) had any dementia; (5) or if they were younger than 18 or older than 65 years old. In total, 156 patients (100 females and 56 males) were enrolled in this study. Each patient was examined by two physicians and evaluated for MS and RLS. They each had an MRI as well.
The results of this study showed:
• 91 (58.3%) patients never had RLS symptoms.
• 51 (32.7%) patients had RLS symptoms more than once a week in the last 6 months.
• 12 (7.7%) patients had RLS symptoms less than once a week in the last 6 months.
• 2 (1.3%) patients had prior history of RLS but no active symptoms.
The Bottom Line: In patients with MS, the rate of RLS is three times higher than the average population. The researchers in this study suggest that MS be considered a cause of secondary RLS.
New Questions: The brain lesions of MS can be found in many places, but there was no association between the locations of the brain lesions and whether the patient also had RLS or not—why is this? What is it about MS that makes a person at higher risk for RLS?
* * * * *
RLS and Transplants.
Restless legs syndrome in lung transplant recipients. Minai OA, Golish JA, Yataco JC, Budev MM, Blazey H, Giannini C. J Heart Lung Transplant. 2007;26(1):24-29.
Background: There has been very little research on transplant patients and RLS. In one study, 45% of heart transplant recipients with periodic limb movements were diagnosed with RLS.
Research: The researchers in this study found 42 patients who had received a lung transplant. All the patients were on standard therapy which included immunosuppresion and prophylactic medicines. To be in the study, theses patients could not have a family history of RLS. These patients filled out two questionnaires. The first was to determine if they met criteria for RLS, and the second was to determine the severity of RLS if present.
The results of this study showed that 47.6% (20 of 42) of the patients had RLS. Of those with RLS, 80% had symptom severity that placed them in the moderate to severe category. Of interest, 75% of those diagnosed with RLS were women. All of the patients that were hypothyroid (4 of 42) had RLS. Also, the patients with RLS had a higher concentration of calcium in their blood than the patients without RLS. Finally, the patients with RLS were more likely to test positive for cytomegalovirus (CMV), a virus that is found in transplant patients, due to the immunosuppression medications.
The Bottom Line: Lung transplantation significantly increases a person’s chance of getting RLS. The risk increases if that patient is a woman, if they are hypothyroid, if they have higher calcium levels, or if they test positive for CMV.
New Questions: What is it about transplant recipients that increases their risk of getting RLS— the immunosuppression medications, the prophylactic medications, how the body responds to a new organ, or something else entirely? Does CMV infection cause RLS or could it possibly be exposure to the medication that treats it?
High prevalence of restless legs syndrome in multiple sclerosis. Manconi M; Fabbrini M; Bonanni E, Filippi M, Rocca M, Murri L, Ferini-Strambi L. European Journal of Neurology. 2007;14:534-9.
Background: Multiple sclerosis (MS) is a chronic disease that affects the central nervous system. It can cause a variety of symptoms involving sensation, vision, speech, strength, mobility, and pain. “Secondary RLS” is a term used to describe RLS that has either a known cause or a known association. Some of the neurological diseases associated with RLS are peripheral neuropathy, spino-cerebellar ataxia, and Parkinson’s disease. Patients with MS often complain of RLS symptoms. This has always been viewed more as coincidence than as a real association between these two conditions.
Research: The researchers wanted to see how common RLS was in patients with MS. Over the course of one year, every patient with MS that came to one of the two neurology clinic research sites was evaluated for this study. Patients were not allowed to be in the study if they had any other neurological condition or other medical condition that could cause secondary RLS. They were also excluded if they were on dopaminergic or neuroleptic drugs or clonazepam, and if they: (1) were diagnosed with MS within 6 months; (2) their MS had relapsed within the last 6 months; (3) had any drug or alcohol abuse; (4) had any dementia; (5) or if they were younger than 18 or older than 65 years old. In total, 156 patients (100 females and 56 males) were enrolled in this study. Each patient was examined by two physicians and evaluated for MS and RLS. They each had an MRI as well.
The results of this study showed:
• 91 (58.3%) patients never had RLS symptoms.
• 51 (32.7%) patients had RLS symptoms more than once a week in the last 6 months.
• 12 (7.7%) patients had RLS symptoms less than once a week in the last 6 months.
• 2 (1.3%) patients had prior history of RLS but no active symptoms.
The Bottom Line: In patients with MS, the rate of RLS is three times higher than the average population. The researchers in this study suggest that MS be considered a cause of secondary RLS.
New Questions: The brain lesions of MS can be found in many places, but there was no association between the locations of the brain lesions and whether the patient also had RLS or not—why is this? What is it about MS that makes a person at higher risk for RLS?
* * * * *
RLS and Transplants.
Restless legs syndrome in lung transplant recipients. Minai OA, Golish JA, Yataco JC, Budev MM, Blazey H, Giannini C. J Heart Lung Transplant. 2007;26(1):24-29.
Background: There has been very little research on transplant patients and RLS. In one study, 45% of heart transplant recipients with periodic limb movements were diagnosed with RLS.
Research: The researchers in this study found 42 patients who had received a lung transplant. All the patients were on standard therapy which included immunosuppresion and prophylactic medicines. To be in the study, theses patients could not have a family history of RLS. These patients filled out two questionnaires. The first was to determine if they met criteria for RLS, and the second was to determine the severity of RLS if present.
The results of this study showed that 47.6% (20 of 42) of the patients had RLS. Of those with RLS, 80% had symptom severity that placed them in the moderate to severe category. Of interest, 75% of those diagnosed with RLS were women. All of the patients that were hypothyroid (4 of 42) had RLS. Also, the patients with RLS had a higher concentration of calcium in their blood than the patients without RLS. Finally, the patients with RLS were more likely to test positive for cytomegalovirus (CMV), a virus that is found in transplant patients, due to the immunosuppression medications.
The Bottom Line: Lung transplantation significantly increases a person’s chance of getting RLS. The risk increases if that patient is a woman, if they are hypothyroid, if they have higher calcium levels, or if they test positive for CMV.
New Questions: What is it about transplant recipients that increases their risk of getting RLS— the immunosuppression medications, the prophylactic medications, how the body responds to a new organ, or something else entirely? Does CMV infection cause RLS or could it possibly be exposure to the medication that treats it?